The introduction of immune checkpoint inhibitors has revolutionized the treatment of lung cancer. However, immunotherapy is highly specific, and a number of factors govern its success. These include a thorough understanding of the immune evasion mechanism of tumor cells and their microenvironment and a rigid patient selection procedure. To gain more insights on this topic, join us for an exclusive session on “Immunotherapy in Lung Cancer” with the eminent oncologist Dr.
Vinayak M on 26 th December, 6:00 PM IST onwards. Stay tuned!
